NDC 71335-1053 – Acyclovir

Acyclovir 400 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC71335-1053

Product details

Brand name
Acyclovir
Generic name
Acyclovir
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA075382
Marketed since
October 22, 2009
Listing expires
December 31, 2026
Pharmacologic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Acyclovir →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1053-0120 TABLET in 1 BOTTLE (71335-1053-0)Nov 13, 2019
71335-1053-120 TABLET in 1 BOTTLE (71335-1053-1)Feb 19, 2019
71335-1053-228 TABLET in 1 BOTTLE (71335-1053-2)Feb 6, 2020
71335-1053-330 TABLET in 1 BOTTLE (71335-1053-3)Jan 28, 2019
71335-1053-450 TABLET in 1 BOTTLE (71335-1053-4)Jan 15, 2019
71335-1053-515 TABLET in 1 BOTTLE (71335-1053-5)Jun 1, 2020
71335-1053-660 TABLET in 1 BOTTLE (71335-1053-6)Jan 8, 2019
71335-1053-725 TABLET in 1 BOTTLE (71335-1053-7)Mar 2, 2021
71335-1053-810 TABLET in 1 BOTTLE (71335-1053-8)Jan 3, 2020
71335-1053-940 TABLET in 1 BOTTLE (71335-1053-9)Aug 24, 2022

Other Acyclovir products